Rapid Micro to Announce Third Quarter 2021 Financial Results on November 11, 2021

Rhea-AI Summary

Rapid Micro Biosystems (Nasdaq: RPID) will release its third quarter 2021 financial results on November 11, 2021, after market close. A conference call is scheduled for November 12, 2021, at 5:00 AM PT, where company management will discuss the results. The call will be accessible via live webcast on their website and archived for 90 days. Rapid Micro provides automation solutions to enhance the production and release of healthcare products, including biologics and vaccines, while ensuring compliance with quality control regulations.

Positive

• Provides innovative automation solutions for healthcare product manufacturing.
• Improves operational efficiency and compliance with data integrity regulations.

Negative

• None.

Conference Call to Discuss Results on November 12, 2021 at 5:00am Pacific Time/8:00am Eastern Time

LOWELL, Mass., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro” or the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that it will release financial results for the third quarter of 2021 after market close on Thursday, November 11, 2021.

Conference Call Details

Company management will host a webcast conference call to discuss third quarter 2021 financial results beginning at 5:00am Pacific Time/8:00am Eastern Time on Friday, November 12, 2021. The conference call will be available to interested parties via live webcast on the Company’s website at https://investors.rapidmicrobio.com/. The webcast will then be archived and available for replay for at least 90 days following the event.

About Rapid Micro Biosystems

Rapid Micro Biosystems is an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company’s flagship Growth Direct® System automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the largest and most complex pharmaceutical manufacturing operations across the globe. The Growth Direct® System brings the quality control lab to the manufacturing floor, unlocking the power of in-line/at-the-line MQC automation to deliver faster results, greater accuracy, increased operational efficiency, better compliance with data integrity regulations, and quicker decision making, that customers rely on to ensure safe and consistent supply of important healthcare products. The Company is headquartered and has U.S. manufacturing in Lowell, Massachusetts, with global locations in Switzerland, Germany, and the Netherlands. For more information, please visit www.rapidmicrobio.com or follow the Company on Twitter at @rapidmicrobio or on LinkedIn.

FAQ

When will Rapid Micro Biosystems release its third quarter 2021 financial results?

Rapid Micro Biosystems will release its third quarter 2021 financial results on November 11, 2021, after market close.

What time is the conference call for Rapid Micro's Q3 2021 results?

The conference call to discuss Rapid Micro's third quarter 2021 results will be held on November 12, 2021, at 5:00 AM PT.

How can I access the conference call for Rapid Micro's Q3 results?

The conference call can be accessed via live webcast on Rapid Micro's website.

What products does Rapid Micro Biosystems focus on?

Rapid Micro Biosystems focuses on automation solutions for the manufacturing and quality control of biologics, vaccines, cell and gene therapies, and sterile injectables.